All collected data are shown in Table 1. To date, 396 heart transplant patients are still alive. Six patients developed active SARS-CoV-2 infection: 2 of these patients died, 1 of acute respiratory distress syndrome and the other of sepsis. All included patients who had heart transplants had the positive reverse transcriptase-polymerase chain reaction nasopharyngeal swab test for SARS-CoV-2 and were symptomatic with fever, cough and shortness of breath. Of the 6 patients, the only female in the study presented mild symptoms and remained in self-quarantine at home. The rest of our cohort was hospitalized in Northern Italy; they had moderate-to-severe symptoms, such as fever for more than 5 days, oxygen saturation below 90% requiring supportive care and signs of pneumonia on radiographs.